Disease Specific Interactions between Host Protein and DME (HOSPPI) |
Drug co-metabolism |
Cometabolized drug: Levodopa |
Click to Show/Hide the Full List of HOSPPI: 3 HOSPPI
|
Cytochrome P450 2D6 (CYP2D6) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0009
DME Info
|
Uniprot ID |
|
Interaction Name |
CYP2D6-tdc interaction |
[1], [2], [3] |
Description |
The interaction, between human Cytochrome P450 2D6 and Tyrosine decarboxylase from Enterococcus faecalis which collectively metabolize the drug Levodopa, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
DOPA decarboxylase (DDC) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0125
DME Info
|
Uniprot ID |
|
Interaction Name |
DDC-tdc interaction |
[1], [2], [4] |
Description |
The interaction, between human DOPA decarboxylase and Tyrosine decarboxylase from Enterococcus faecalis which collectively metabolize the drug Levodopa, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Thiopurine methyltransferase (TPMT) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0014
DME Info
|
Uniprot ID |
|
Interaction Name |
TPMT-tdc interaction |
[1], [2], [5] |
Description |
The interaction, between human Thiopurine methyltransferase and Tyrosine decarboxylase from Enterococcus faecalis which collectively metabolize the drug Levodopa, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
|
|
|
|
|
|